Diebold Nixdorf, Incorporated
DBD
$61.70
$1.692.82%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.95% | -2.61% | -6.06% | -4.62% | -1.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.95% | -2.61% | -6.06% | -4.62% | -1.73% |
| Cost of Revenue | 1.75% | -3.33% | -6.26% | -7.33% | -6.29% |
| Gross Profit | 2.52% | -0.53% | -5.50% | 5.16% | 14.00% |
| SG&A Expenses | 1.29% | 4.23% | 0.07% | -3.08% | -0.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -93.33% | 105.56% | -70.00% | -138.46% | -- |
| Total Operating Expenses | 1.17% | -1.83% | -5.20% | -6.95% | -4.98% |
| Operating Income | 10.49% | -10.82% | -18.02% | 27.65% | 56.40% |
| Income Before Tax | 525.61% | -62.61% | 43.27% | -44.39% | -99.63% |
| Income Tax Expenses | -67.89% | -85.00% | 29.03% | 466.67% | -63.04% |
| Earnings from Continuing Operations | 292.17% | -14.19% | 46.43% | -72.05% | -101.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 14.29% | -600.00% | -33.33% | -33.33% | -40.00% |
| Net Income | 283.48% | -18.12% | 43.15% | -74.89% | -101.05% |
| EBIT | 10.49% | -10.82% | -18.02% | 27.65% | 56.40% |
| EBITDA | 8.55% | -7.00% | -10.98% | 19.17% | 28.15% |
| EPS Basic | 289.02% | -17.23% | 43.16% | -74.89% | -101.58% |
| Normalized Basic EPS | 66.75% | -42.06% | -51.61% | 3.56% | 746.95% |
| EPS Diluted | 285.00% | -17.23% | 43.16% | -74.89% | -101.61% |
| Normalized Diluted EPS | 64.51% | -42.36% | -51.61% | 3.56% | 754.81% |
| Average Basic Shares Outstanding | -2.93% | -1.06% | 0.00% | 0.00% | -33.98% |
| Average Diluted Shares Outstanding | -1.60% | -0.53% | 0.00% | 0.00% | -34.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |